Biocon

Goldman Sachs will be issued Optionally Convertible Debentures at a post money equity valuation of $3.94 billion

The Top 5 global players in this year’s list are Regeneron, Alnylam, Incyte, Syngenta and Biocon

She will become a member of the board's Remuneration and Nomination Committees

Experts share insights on how smart packaging technologies are evolving and the significant benefits they can bring to the pharma…

Before joining Biocon, Jindal held the position of Group CFO at Sterlite Technologies since 2006

Juilee Dandekar, Sector Expert - Healthcare, Business Research & Advisory, Aranca informs that with India Pharma Inc's…

Shaw informed about it through a tweet and said, “Mild symptoms and I hope it stays that way”

Post the completion of this transaction, Biocon will hold 95.25 per cent stake in Biocon Biologics

The company's Research Services business reported flat revenue growth at Rs 422 Crore due to slowdown of operations impacted by…

"If the Bharat Biotech vaccine, or Zydus Cadila vaccine starts showing good, promising results, we could also have it (vaccine) by…